More Than 2 mln Cancer Patients Treated with BrainLAB m3 Shaped Beam Radiosurgery
13th Nov 2006, 18:21 GMT
250th m3 High-Resolution Multileaf Beam Shaper at UMC Health System
More Than 2 mln Cancer Patients Treated with BrainLAB m3 Shaped Beam Radiosurgery related news:
- New Treatment Finds Success, Long Survival In Treating Tiniest Lung Tumors, — Health News from Medical News Today
- Recurrent breast cancer: Drug shows promise — The Cancer Blog
- 'WHEN YOU'RE AT YOUR MOST VULNERABLE, APPEARANCE MATTERS' ; Consultant Oncologist Hilary Thomas Has Treated Cancer Patients for Years. But the One Thing She Had Never Prescribed, Until She Was Diagnosed With the Disease Herself, Was a Large Dose of Self-E — RedOrbit News - Health
- Celebrex for treatment of precancerous cervical changes — The Cancer Blog
- Quality care assessment examines surgical quality for colorectal cancer patients — EurekAlert! - Breaking News
- Bumper-to-bumper traffic jams M3 — IOL: South Africa
- Health policy for cancer patients in Bihar — NK India News
- Vistec Electron Beam — Semiconductor Technology
- Patients respond to health recall — BBC News | UK News | England | West Midlands | World Edition
- Shorter-course Radiation Treatment Safe For Breast Cancer — Health News from Medical News Today
Latest news from StratWire - Business of Healthcare NewsFeed:
- Alliance Names New COO
- NHCAA to Award Those Who Fight and Expose the Deadly Side of Health Care Fraud
- PA's Continuing Trend Towards Total Body Reconstruction Keeps Consumers Demanding Comprehensive Direct-To-Consumer-Education (DTCE )
- Dr Farzad Yaghouti of Global Laser Vision San Diego Wins 'Best Lasik Surgeon 2006'
- 1st Study to Evaluate WelChol/Ezetimibe and Simvastatin Effect on LDL-C Finds Additional Lipid Parameter Benefits
- Medical Mutual of OH Financial Investigator Wins Top Nat'l Fraud-Fighting Award
- Intelligent Medical Objects and Bond Technologies Sign Multi-year Agreement
- M-CARE's Medicaid Plan Recognized as One of the Top Health Plans by US News & World Report/NCQA
- Fitch: MCH rates 'A-' on bonds
- Vioxx-Like Drug Gets Mixed Reviews